Digital Therapeutics Market Overview 2021-2026:
According to IMARC Group latest report titled “Digital Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, offers a comprehensive analysis of the industry, which comprises insights on digital therapeutics market outlook. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The market is currently witnessing strong growth. The global Digital Therapeutics Market to grow at a CAGR of 22% during 2021-2026.
Digital therapeutics (DTx) is a subset of cognitive-behavioral therapy that is utilized to deliver evidence-based treatment interventions to patients. It adopts various software programs, wearable devices, digital data, and an internet connection to diagnose, treat, prevent, and manage physical and mental illnesses. They find application in conditions, such as Alzheimer’s disease, type 2 diabetes, asthma, gastrointestinal problems, and chronic pulmonary disease. DTx can be used as a standalone therapy or in conjunction with conventional treatments, including in-person and pharmacological therapies, to enhance the effectiveness of health care.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
The DTx market is majorly being driven by the rising prevalence of chronic diseases, along with the shifting inclination toward preventive treatment solutions and the increasing need to lower healthcare costs. Additionally, the inflating sales of smart devices due to the availability of high-speed internet connectivity has further led to an increase in the adoption of digital devices amongst consumers for accessible, engaging, and personalized medical solutions. This, in turn, is contributing to the market growth. Moreover, rising awareness regarding the benefits of DTx, such as patient convenience, and improved drug compliance, is acting as another growth-inducing factor. Other than this, leading pharmaceutical companies are consistently investing in research and development (R&D) activities to introduce advanced production technologies and expand their product portfolio, which is creating a positive outlook for the market.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/digital-therapeutics-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- 2Morrow Inc.
- Canary Health Inc.
- Click Therapeutics Inc.
- Mango Health Inc.
- Noom Health Inc.
- Omada Health Inc.
- Pear Therapeutics, Inc.
- Propeller Health
- Teladoc Health Inc.
- Voluntis Inc.
- WellDoc Inc
Digital Therapeutics Market Segmentation:
Our report has categorized the market based on region, application and end use.
Breakup by Application:
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
Breakup by End Use:
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Leave a Reply